Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Illumination Tool Reduces Gallbladder Removal Risk

By HospiMedica International staff writers
Posted on 08 Nov 2015
A novel imaging solution utilizes back-lit illumination of the biliary tree to reduce the risk of injury during laparoscopic cholecystectomy. More...


Under development by researchers of the BioDesign team at the Hebrew University (HUJI; Jerusalem, Israel) and Hadassah Medical Center (Jerusalem, Israel), the CholeVision dedicated laparoscopic tool will help surgeons avoid bile duct injuries and their devastating consequences by optically contrasting bile ducts and surrounding tissues, without changing the standard laparoscopic procedure. This is made possible due to characteristic visible red spectrum wavelength absorption by bile acids.

By using a solid-state fiber optic light source which is inserted into a clip applier or a standard clamp, light at a red wavelength range of 600-700 nm preferentially absorbed by bile acids can be directed to illuminate the surgical field. When switching the color and direction of incident light, the bile duct anatomy can thus be made visible without the need for intravascular injection of fluorescent dyes, ultrasound imaging, or X-ray images, significantly reducing the complexity of the laparoscopic procedure.

“The laparoscopic procedure is so simple and fast that surgeons are reluctant to make it complex by adding new imaging modalities,” said Muhammad Adileh, MD, a surgeon who led the HUJI BioDesign team. “We had to find a solution that wouldn’t complicate things by changing the procedure or increasing operation time.”

“We found that red light in the visible range is predominantly absorbed by bile acids in the biliary tree,” added Prof. Yaakov Nahmias, PhD, director of the HUJI Center for Bioengineering. “This is a significant discovery, allowing surgeons to carry out the standard laparoscopic procedure and identify bile ducts with a single flip of a button.”

In traditional laparoscopic cholecystectomy, four incisions are made in the abdomen: one on the rim of the navel, one beneath the navel, and two beneath the navel and to the right. A laparoscope and surgical instruments are passed into the interior of the abdomen to aid the surgeon in removal of the gallbladder. The most common reason for cholecystectomy is cholelithiasis, caused by gallstones trapped inside the gallbladder duct that trigger intense abdominal pain that usually lasts between one and five hours.

Related Links:

Hebrew University
Hadassah Medical Center



Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Surgical Headlight
IsoTorch
Emergency Ventilator
Shangrila935
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.